chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experienced foot drop. I was sitting, then stood up and tried to turn right. Lost motion in my right foot when trying to turn to walk away. After that, had tingling sensation in both arms and tongue for 10 - 15 minutes. Since the initial event, I have had a tingling/numbness sensation below my knee on my right leg, on the outside of my leg extending down to my toes and on the top of my foot. The inside of my leg feels fine so does the bottom of my foot. I can move my foot from side to side and point my foot and toes down, but I have weakness and lack of mobility when pointing my foot and toes upwards. When trying to stand on toes my right foot buckles. Can't walk on my right heel.
After vaccination in the evening patient has a mild complaint of throat burning.   Patient went to bed and awoke at 4AM with severe arm pain which was managed with an ice pack.  Patient was able to sleep for about an hour, awoke with headache, body aches, sore kidneys, and a queasy stomach.  Also complain of metallic taste on her tongue.   Patient has taken tylenol and cough suppressants for symptoms.  Had similar symptoms after first vaccine, but these are worse.  Patient likely would not have gone to work except for strict attendance policy.
Patient developed gangrene of the left hand several days after receiving the vaccine. She also developed open sores on her left hip that have not progressed to gangrene yet.
Pt DOB 1/1/1988. Pt in post observation post 1st dose of Pfizer vaccine. Pt states feeling dizzy while climbing the stairs. Pt states she was able to eat her breakfast. Pt states that the room is rotating. Client was given water and juice, O2 sat and pulse were obtained by RN and EMS was called by RN. EMS evaluated Pt. EMS released Pt from care and d/c home. Client stood up and states that she "feels better" and is no longer dizzy. Husband states he will drive Pt home.
Pt reports localized swelling and warmth to the left upper arm that occurred approximately 12 hours after administration. Recommended cold compress/ice pack to the area as well as OTC children's ibuprofen or Tylenol. Appt for eval scheduled at the pt's PCP clinic the day after vaccine administration.
pt recv vax 7AUG95 & devel varicella 19FEB98 w/greater than 30 pox in first 12hr w/T>103;
4 hours after the vaccination, I felt exhausted and I went to sleep at about 4:00 pm. I was exhausted for 3 days. I took over the counter anti-inflammatory medicine. I feel more forgetful after the vaccination. I visited my doctor for a check up that month and mentioned to him my symptoms of the vaccine.
Within 1-2 hrs after vaccination, area red and warm. Office visit: macular, pink-red inflamed area size approx 4 inches across left deltoid. No red streaks. Improving after 1 day. Ibuprofen and ice.
4days p/vax pt exp febrile on 7/17/99 to 102.5, rash on abd, 7/18/99, erythema macular .also diarrhea.
pt recv vax 31JUL97 & w/in 24hr pt exp an exacerbation of sickle cell crisis;this resulted in joint pain;pt has a prescription for APAP #3 for as needed treatment; sx are currently ongoing;
Patient came in for a "booster" shot and received an incorrect dose of 0.5 ml Moderna Covid vaccine. Should have been 0.25 ml.
Vax received on 08/05/96. On 09/25/1999, the pt experienced a fever. The following day, she developed 50-60 skin lesions. Medical attention sought (NOS). On 09/29 she was afebrile. Follow-up information received and noted that on 09/30 she developed 50 more skin lesions since the day prior. As of 10/01, she had a total of 200 skin lesions. She was treated with hydroxyzine dihydrochloride and ciprofloxacin monohydrochloride monohydrate ophthalmic drops. She recovered.
I26.99 ACUTE PULMONARY EMBOLISM 4/12/2023 DM 2 WO COMPLICATIONS
On 03/02/2006 patient had onset of emesis and fever.  Seen at urgent care.  Flushed cheeks and increased bowel sounds.  Seen on 03/03/2006 for onset of rash, had papules and some petechiae and fever to 103 degrees.  Seen on 03/06/2006 for spreading rash.  Papular on extremities, torso, and some lacey rash as well.
Vaccine given 8/9/18. Morning of 8/13/18 with urticaria of elbows, proximal dorsal forearms and distal thighs (above knees). There were no obvious precipitating events for the urticaria.
The day of the vaccination's administration the site was red and irritating.  Patient was scratching at it and saying it hurt.  The next morning it was swollen, red and hot and he continued to scratch at it.  Throughout the morning it got worse, to the point it was about 3 inches in radius from the injection site, raised and swollen, and still hot and itchy.  We called the dr.  They had us come in, saying it was probably an allergic reaction.  Upon examining it, they confirmed that it was an allergic reaction and told us to give him benedryl.  We gave him the benedryl and by the next morning the size of the red patch was noticeably reduced and he had stopped scratching.  The area remained discolored for a few weeks afterward.  It faded to a brownish-purple color, like that of a liver spot, then eventually disapeared.
This spontaneous report as received from a physician refers to a female patient of unknown age. On 09-AUG-2017 the patient was vaccinated with PNEUMOVAX 23, subcutaneous for prophylaxis. Other suspect therapies included M-M-R II. On 09-AUG-2017, 1 day after onset of therapy the patient experienced wrong technique in product usage process. On an unknown date the patient experienced no adverse event. The outcome of wrong technique in product usage process and no adverse event is unknown.
My shoulder and arm were very sore (painful) Sat and Sun and then bruise come out on Mon. and then was getting bigger and bigger. I couldn't lift my arm. Health Dept and Dr said that I will be ok. She recommended to take Ibuprofen. Next day got bigger, arm felt warm. I went to see my PCP.
pt recv vax & devel a fever of 101;the next day pt c/o h/a, dizziness & funny feeling;
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Patient fained a few minuies after injection. Felt hot then tried to get up and fell to the ground. She was not injured. EMS was called and evaluated her. No signs of anaphylaxis.
100 degree + fever following injection. Fever continuing until the current time (100.4) at 8:45. Headaches, Body Aches, Chills, & Nausea are still occurring.
RASH ABOUT 3 INCHES CIRCLING VACCINE SITE  ALL THE WAY AROUND ITCHY RAISED
Per Department of Health: Regarding The Data Base for Health Agency on the following COVID Vaccine Moderna. Please see the following determination; Doses Administered from 4.6.2021 to 5.21.2021:Based on the information you have provided and the lack of temperature data, we are not able to conduct an analysis or guarantee the doses administered between 4/6/2021 and 5/21/2021 provided the necessary protection against a COVID-19 infection. Please continue with the original plan of action on revaccination and completing a VAERS Reports on the all clients you have identified.
c/o arm hurting more so than other times received injection, Determined by MD that injection may have been given to high and nicked the bursa. Patient had ROM but states that the shoulder hurt. Patient was placed on Naproxen twice daily
5 mins after injection pt became pale sweating did not pass out cool cloth to head elevated legs juice and crackers. Better after 15 mins.
Fatigue, sore arm, muscle aches, headache, and dizzy. Vertigo for several days.
Treatment of COVID-19; Treatment of COVID-19; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 as dose 5 (booster), single (Lot number: GJ3277) at the age of 51 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 09Apr2020 as dose 1, single (Lot number: 026B21A), in left arm, on 07May2021 as dose 2, single (Lot number: 002C21A), in left arm, on 17Dec2021 as dose 3 (booster), single (Lot number: 058H21A), in left arm and on 03May2022 as dose 4 (booster), single (Lot number: 056M21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Bipolar depression" (unspecified if ongoing); "Dementia" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "ADD" (unspecified if ongoing); "GERD" (unspecified if ongoing). Concomitant medication(s) included: IRON; MIRTAZAPINE; BUPROPION HYDROCHLORIDE; OMEPRAZOLE; DEXAMPHETAMINE; LAMICTAL; GABAPENTIN; METFORMIN. Past drug history included: No, reaction(s): "Allergy". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 27Oct2022, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (10Mar2023) Negative; (14Mar2023) Negative. Therapeutic measures were taken as a result of drug ineffective, COVID-19.  Clinical Course: The patient was treated with paxilovid-19 for covid-19 from 04Mar2023to 09Mar2023.
The first one on 16 April 2021 and the second one on 07 July 2021; heavy, heavy menstrual cycle bleeding; major bleeding; severe muscle pains; Lethargy; just slept it off; felt completely run down/just felt horrible; This is a spontaneous report from a contactable consumer.   A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 07Jul2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE (at unspecified age) for covid-19 immunisation.  Patient was unable to provide NDC, Lot, expiry, or dose/strength for either Covid vaccine doses. She does not have card with her since she is at work. No other vaccines given the same day or 4 weeks prior. No problems with vaccines in past. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient had history of heavy, heavy menstrual cycle bleeding; major bleeding, severe muscle pains, lethargy, felt completely run down, felt horrible following the first dose of BNT162B2.  The patient had dose 1 of BNT162B2 for Covid-19 immunization on 16Apr2021, administered to left arm. After the first dose patient experienced heavy, heavy menstrual cycle bleeding; major bleeding, which is very unusual for her, she had severe muscle pains, just slept it off, felt completely run down/just felt horrible for 4-5 days and lethargy that occurred for 3 weeks afterwards. She waited to get the second dose because she had side effects after she took the first dose. Then it happened again after the second dose.  The patient experienced heavy, heavy menstrual cycle bleeding; major bleeding (medically significant) on 2021 with outcome of unknown , severe muscle pains on 2021 with outcome of recovering , lethargy on 2021 with outcome of recovering , just slept it off on 2021 with outcome of recovering , felt completely run down/just felt horrible on 2021 with outcome of recovering, the first dose taken on 16Apr2021 and the second one on 07Jul2021 on an unspecified date with outcome of unknown.  The patient did not seek medical attention or treatments after events.  Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101042048 same patient/drug, different dose/AE dose 1
Pt relates that she received the vaccine at a Flu clinic and the person was rough and now she has pain, swelling, and pain going to her left side of her neck and left shoulder
Patient was given a booster of Moderna COVID vaccine on 3/30/22 which was too early. Due to late reporting (delay in data transfer.  data had been referenced to verify eligibility for booster. During an audit it was discovered that the 1/19/22 booster administration information did not transfer in a timely fashion thus making it look like he was eligible for his booster on 3/30/22.  Outpatient clinic treatment team leader notified patient and reminded him to contact his doctor.
PATIENT HAD PAINFUL ARM FROM SHOULDER TO ELBOW.  ARM WAS SWOLLEN, RED, HOT AND PAINFUL. PATIENT FELT LIKE SHE HAD FLU LIKE SYMPTOMS ALSO.
On October 20, 2021, 12 days after getting the vaccine, I had 4 rash like spots on my left lower back. They were itchy and I had some pain at the site of the rash. The second day the spots were larger and I had a few more spots.  On day 14 I had rash like spots on my left lower torso and the rash on my back started to get fluid filled spots.   On Saturday, October 23, 2021 I went to urgent care and the doctor diagnosed me with shingles.  The Doctor prescribed Lidocaine patches for the pain, Valacyclovir and calamine lotion for the itch.
Fever greater than 101 degrees F, chills, shortness of breath, Hospitalized 10/11/02 through 10/16/02 and 10/19/02 through 10/24/02. Death certificate received on 2/19/2003 indicates end stage COPD as the cause of death.
- ten minutes after shot my top front teeth felt numb and I started to feel waves of hyper-awareness and disequilibrium that were accompanied with mild nausea.  The numbness in teeth went away after approximately 5 min. The waves of disequilibrium continued for 24hrs, and now feel more like a pressure headache.  During these ?waves? I also had increased heart rate.  - an hour after the shot, my left arm felt numb down to the fingers. Then the right arm and upper back. This subsided after an hour.
I received  a flu shot at 4:00 PM.  I started becoming depressed around 10:00 PM.  By 12:00 PM I could not stop crying and kept stating I wanted to die.  There were no triggers that I can identify for this extreme reaction, and I have never felt suicidal to this extent.  I have a great deal of support and they found me in a corner of the living room.  Since I am a MD, we were able to sedate with a benzodiazapen.  I was still somewhat sad this morning and I have flu symptoms that are on going since this morning.
My lymph node above my left shoulder blade was swollen.; This is a spontaneous report from a contactable consumer (patient). A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), administered in left arm, on 27Jan2021 at 09:30 AM (at the age of 25-years-old) at 1st dose, single for COVID-19 immunisation. Medical history included known allergies: pollen. No COVID prior vaccination and no COVID tested post vaccination. Concomitant medications were not reported. No other vaccine received in four weeks and no other medications in two weeks. The patient reported that his lymph node above the left shoulder blade was swollen on 30Jan2021 at 08:30 AM. He went to receive an ultrasound in 2021 to confirm. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was received due to the event. The patient then received the second dose of BNT162b2 (lot number: EL3247) on 17Feb2021 at 08:30 AM, administered in left arm for COVID-19 immunisation. The patient was recovering from the event.
My shot was on Saturday 3/26 and I started having a fever (101), body aches, pulse was elevated to around 75 bpm through Monday 3/29 late afternoon. Not sure if this helps but I had contracted  COVID-19 in mid-March 2020 and had been giving COVID convalescent plasma for several months up until February of 2021. Maybe my previously generated antibodies amplified my symptoms?
felt tired; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th October 2020, the patient received the 1st dose of Shingrix. In October 2020, less than 2 weeks after receiving Shingrix, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the fatigue to be related to Shingrix.  Additional details were provided as follows: The age at administration was not reported. The patient received the 1st dose of Shingrix and felt tired which was resolved in 24 hours. The reporter did not consented to follow up. No further information was available.
COVID-19; COVID-19; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 OMI ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation; BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Per clinical course, the patient called in regard to the Pfizer COVID-19 Vaccine testing kit. The patient needed 3 testing kits since she has COVID-19, and she already received all the vaccinations and booster shot.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
(R) deltoid erythema - developed 3 days after vaccine given. As of 8/24, 1 wk after vaccine, approx 15cm x 8cm affected area.
Mild Nausea; arm was red from the injection site down to just above my elbow; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007N20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (soreness). On 02-Feb-2021, the patient experienced NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow). At the time of the report, PAIN (soreness), NAUSEA (Mild Nausea) and VACCINATION SITE ERYTHEMA (arm was red from the injection site down to just above my elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication information was provided. No treatment information was provided by the reporter.     On 01 Feb 2021, patient got her 1st dose of the Moderna vaccine. Patient  reported soreness on the1st day. The next day on 02Feb2021, her arm was red from the injection site down to just above her elbow. Patient felt tired, and had mild nausea.
Patient had 5 mins. left on his 15min observation period. He then became nauseated and vomited. EMS onsite move the patient to the ambulance for assistance. BP 185/126 , HR 102, Temp. 98.6, O2 Sat 98% on RA. BS=123. Checked again BP 207/120 on monitor manual BP 210/102. Patient was advised to go to ER for follow up. Patient transported to the Hospital.
This is a 13 month old child presenting with difficulty breathing and skin reaction to vaccination. The child had noted a spot on the thigh from Tuesday vaccination, thus about 2 days ago. This has been reddened and swollen. They tried some Benadryl and Tylenol. Tonight there seemed to be an episode that was scary. It seemed like the breathing was hard and labored with perhaps some retractions. The child was fussy. The child had difficulty sleeping, but as soon as the child was picked up and evaluated she seemed to improve. There did not seem to be anything for sure that seemed to make her better such as taking her outside or any events, perhaps just comforting. Thus, she was brought in as this was scary and to review to see if this reaction has caused it. The child has had no fever. The child has been fussy because of the discomfort in the leg. The left thigh shows a 2x3 red injury with no flucturance, no streaking. There is no excessive heat to the area, but it is warm. the child is doing well now and will be discharged. Advised to continue to treatments they have been giving with Benadryl and Tylenol. She does not seem to require any antibiotics at this time. The breathing episodes seems transitory. This possibly could be a viral situation, but I think it is a little bit early to tell. Croup may also give this kind of situation, although there does not seem to be any clear entity of that either. Thus, I will send the child home with observation. Perhaps a vaporizer would help too. Final diagnoses: local reaction to immunization. Attack of dyspnea.
48 year old received Fluzone Quadrivalent High Dose in error/No AE; 48 year old received Fluzone Quadrivalent High Dose in error/No AE; Initial information was received on 18-Sep-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves a 48 year old male patient who received a 0.7 ml once dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] [lot number: UJ484AB and expiry date: 30-Jun-2021] via an intramuscular route in the left arm, on 14-Sep-2020 in error, for prophylactic vaccination (product administered to patient of inappropriate age and overdose).   Medical history, medical treatment, concomitant drugs and family history were not provided. No other vaccines were used.  It was a case of overdose and actual medication error due to inappropriate age at vaccine administration. (Latency: on the same day of vaccination)  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Had abnormal uterine bleeding after first and second dose of Pfizer -Biotech Covid 19 vaccine
This case was reported by a physician via call center representative and described the occurrence of fever in an unspecified number of patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and pain. On an unknown date, the outcome of the fever and pain were unknown. It was unknown if the reporter considered the fever and pain to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The physician stated that patients that were administered the SHINGRIX vaccines experienced light fever and aches.
I developed Graves disease with onset of symptoms of weight loss and tachycardia starting in late November. It took me and my doctor until January 20, 2023, to come up with the diagnosis. I am currently taking methimazole for my Graves disease, my body is responding to the medication well.